松的K+通道提供了对心肌缺血症/再输液损伤的保护
Anna Roslan1, Katharina Paulus1, Jiaqi Yang1
1Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, Auf der Morgenstelle 8, University of Tuebingen, 72076 Tuebingen, Germany.
Cardiovascular research
|August 5, 2024
概括
通过Na+激活的Slack通道对于心脏细胞在缺血和再输血期间的存活至关重要. 松通道活动通过调节离子平衡和对抗压力心脏细胞中的过载来保护心脏损伤.
科学领域:
- 心血管生理学心血管生理学
- 离子通道功能的功能
- 细胞应激反应的应激反应
背景情况:
- Na+ 激活的 Slack (K+) 通道调节神经元活动.
- 它们在心血管系统中的作用,特别是在缺血-再输液 (I/R) 损伤期间,基本上是未知的.
- 细胞内Na+度升高 ([Na+]i) 显著导致心肌I/R损伤.
研究的目的:
- 在病理生理条件下研究Slack通道在心血管系统中的作用.
- 测试Slack通道在心肌I/R损伤中起作用的假设.
主要方法:
- 野生型和Slack淘汰赛小鼠心肌细胞 (CMs) 中K+电流的电生理记录.
- 活细胞成像评估K+流和膜潜力.
- 在使用全球性和CM特异性Slack突变的体内I/R模型.
- 评估线粒体ATP敏感的K+ (mitoKATP) 通道提供的心脏保护.
主要成果:
- 在CM中K+电流依赖于Slack频道.
- 松缺乏导致脱极化膜潜力,过度的Ca2+积累,以及在低氧/低氧化下细胞死亡.
- 在I/R期间,Slack突变体的心脏损伤加剧,并且对机械调节不敏感.
- 需要通过mitoKATP通道进行心脏保护功能 Slack.
结论:
- 松通道对于缺乏氧气的CM中离子稳态至关重要.
- 松活动抵消了I/R期间致命的Ca2+吸收,支持心脏保护信号.
- 松通道是缓解I / R诱导的心肌损伤的关键目标.
相关概念视频
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
941
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
941
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
804
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
804
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
481
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
481